Early Detection Target oncology centers and primary care networks with CellMax Life’s non-invasive, blood-based early cancer detection tools to create pathways for routine cancer screening programs and preventive care services.

Colorectal Focus Leverage the proprietary colorectal cancer screening blood test to pursue partnerships with gastroenterology clinics, screening programs, and insurers looking to expand CRC prevention through non-invasive testing and adenoma detection.

External Validation Highlight independent external validation results showcased at key conferences to engage hospital systems and CROs seeking proven biomarkers and replicable diagnostics to de-risk adoption and scale deployments.

Strategic Advisory Engage potential board and advisory relationships with industry veterans to accelerate clinical adoption, integration into existing workflows, and to open doors with large healthcare networks and payers.

Affordability Edge Position affordability and non-invasive convenience as differentiators to pursue partnerships with payers and value-based care programs aiming to reduce downstream costs from late detection and enable broad population screening.